|
|
||||||||
1,2Department of Clinical Microbiology, Clinical Bacteriology1, and Department of Clinical Microbiology, Immunology2, Umeå University, Umeå, Sweden 3Departments of Medicine and Microbiology, University of Washington, Seattle, WA 98195, USA
Correspondence Anders Sjöstedt anders.sjostedt{at}climi.umu.se
Received March 26, 2004
Accepted June 28, 2004
The highly virulent bacterium Francisella tularensis is well adapted to the intracellular habitat but the mechanisms behind its intracellular survival have been elusive. Recently, it was shown that the bacterium is capable of escaping from the phagosome of human and mouse monocytic cells. Here it is shown that this escape is affected by gamma interferon (IFN-
) treatment of mouse peritoneal exudate cells since in treated cells the proportion that escaped was significantly lower (80 %) than in untreated cells (97 %) as determined by transmission electron microscopy. By contrast, < 1 % of mutant bacteria lacking expression of a 23 kDa protein denoted IglC were able to escape from the phagosome. Infection with the
iglC strain complemented with the iglC gene resulted in 60 % of the bacteria escaping from the phagosome. Whereas IFN-
treatment conferred a static effect on intracellular wild-type bacteria, the treatment had a bactericidal effect on the
iglC strain. The results show that the activation status of infected cells affects the escape of F. tularensis from the phagosome. An even more profound effect on this escape is related to expression of IglC by F. tularensis. Its absence rendered the mutant bacteria incapable of escaping from the phagosome and of multiplying intracellularly.
, gamma interferon; PECs, peritoneal exudate cells. | INTRODUCTION |
|---|
|
|
|---|
) has a key role in this macrophage activation and also for in vivo survival (Anthony et al., 1992; Elkins et al., 1993; Fortier et al., 1992; Leiby et al., 1992; Sjöstedt et al., 1996). In contrast to the numerous studies on the host response to tularaemia, the mechanisms behind the successful intracellular parasitism of F. tularensis are not well understood. For example, the bacterium lacks type III and type IV secretion systems utilized by other successful intracellular bacteria, e.g. Shigella, Salmonella, Chlamydia, Brucella and Legionella (Prior et al., 2001). We have demonstrated that F. tularensis shows few signs of stress when growing intracellularly in macrophages (Golovliov et al., 1997), indicating that it is well adapted to the intracellular habitat despite the fact that it is believed to reside in the hostile environment of endosomes (Anthony et al., 1991). Recently, we provided one explanation for this apparent paradox by the demonstration that F. tularensis has the ability to escape from the phagosome of murine and human monocytic cells (Golovliov et al., 2003a). In our studies, a human vaccine strain, F. tularensis LVS, belonging to subspecies holarctica has been utilized. This strain shows high virulence for mice and replicates very rapidly intracellularly and therefore appears to be an appropriate model for understanding the mechanisms of the intracellular survival of F. tularensis. Our findings were corroborated in a recent study showing that a strain of the highly virulent subspecies tularensis escaped into the cytoplasm of human monocytic cells (Clemens et al., 2004).
We have demonstrated that specific mutants can be created in F. tularensis LVS by generating a mutant designated
iglC (Golovliov et al., 2003b). The IglC protein is a 23 kDa protein that we have previously shown to be one of a few proteins prominently up-regulated during intracellular growth of F. tularensis (Golovliov et al., 1997). The protein shows no similarity to other proteins in GenBank and its function is therefore elusive. We also showed that the
iglC strain was unable to multiply in the mouse monocytic cell line J774.A1 (Golovliov et al., 2003b). In view of this impaired intracellular multiplication, we now ask whether the ability of the mutant to escape from the phagosome was affected and if the activation status of the infected cells influences the escape.
| METHODS |
|---|
|
|
|---|
iglC strain has been previously described and was obtained by allelic replacement of both copies of the iglC gene (Golovliov et al., 2003b). For complementation in trans, plasmid pKK214 containing the GroEL promoter of F. tularensis LVS (Abd et al., 2003) was used. The iglC gene was generated by PCR and cloned into the plasmid. The plasmid was introduced by cryotransformation (Pavlov et al., 1996). Expression of IglC was confirmed by Western blot analysis. For determination of the total fatty acid content, fatty acids were extracted from freeze-dried cells according to the method of Bligh & Dyer (1959) and quantified by GC using an HP 5890 series II gas chromatograph with a 7673 autoinjector (Somerville et al., 1996) (temperature gradient from 40 to 260 °C using a 4 °C min1 ramp). Individual fatty acids were verified by GC-MS.
In vitro infection of mammalian cells and assay of intracellular bacterial multiplication.
Peritoneal exudate cells (PECs) were obtained from mice 3 days after intraperitoneal injection of 2 ml 3 % thioglycolate. PECs were washed with DMEM (Gibco-BRL) and resuspended in culture medium consisting of DMEM with 10 % heat-inactivated fetal calf serum. Cells were seeded out at a density of 1 x 106 cells per well in a 24-well tissue culture plate (for enumeration of bacteria) or at a density of 8x106 cells per well in a 6 cm tissue culture dish (for electron microscopy). After incubation for 2 h at 37 °C with 5 % CO2, nonadherent cells were removed by washing with DMEM. After incubation overnight with or without 100 U IFN-
ml1 (Peprotech) at 37 °C in 5 % CO2, wells were washed and reconstituted with fresh culture medium. To each well, a suspension of bacteria was added and bacterial uptake was allowed to occur for a 2 h period at 37 °C and with 5 % CO2. After bacterial uptake, the monolayer was washed twice and incubated for 2 h in culture medium with 2 µg gentamicin ml1 with or without 100 U IFN-
ml1.
For determination of numbers of intracellular bacteria, cells were washed once and lysed with 0.2 ml 0.1 % sodium deoxycholate in PBS. After addition of 1.8 ml PBS, 100 µl portions of each lysate, serially diluted in PBS, were plated on modified ThayerMartin agar for determination of viable counts.
Electron microscopy.
To evaluate the intracellular localization of F. tularensis LVS by transmission electron microscopy, cells growing as monolayers in cell culture dishes with a diameter of 60 mm were infected following the aforementioned protocol. To visually estimate the content and behaviour of the bacteria in the infected cells, short ribbons of ultrathin sections (8590 nm thickness) were collected on Formvar/carbon-coated single-hole grids. The diameter of the hole (1 mm) allowed us to analyse a series of six to seven consecutive sections of one cell, representing 500600 nm total thickness. To determine the intracellular localization of bacteria, 200 nonconsecutive sections containing readily identifiable bacteria were counted.
Statistical analysis.
Student's t-test and 2-sample test for equality of proportions with continuity correction were used.
| RESULTS |
|---|
|
|
|---|
iglC mutant. Similarly to a previous study (Golovliov et al., 2003b), we observed that the
iglC strain was unable to multiply in monocytic cells. However, there was only a slight but significant decrease over time, 0.8 log10 (P < 0.0002), until 18 h (Table 1). In contrast, F. tularensis LVS replicated and the bacterial numbers increased 1.6 log10 within 18 h (Table 1). Addition of IFN-
to cultures resulted in control of the F. tularensis LVS infection as well and bacterial numbers decreased 1.2 log10 (P < 0.0002 vs c.f.u. at 0 h) within 18 h (Table 1). The corresponding decrease of
iglC bacterial numbers was already highly significant within 5 h, 1.1 log10 (P < 0.00001), and after 18 h, the decrease was 3.8 log10 (Table 1).
|
Intracellular localization of
iglC as determined by transmission electron microscopy
Previously, we demonstrated by electron microscopy that F. tularensis LVS was able to escape from the phagosome of mouse and human monocytic cells (Golovliov et al., 2003a) and the majority of bacteria had a cytoplasmic localization after 2 h. To this end, we determined the intracellular localization of the
iglC bacteria at this time point. The microscopic analysis revealed that 97 % of the F. tularensis LVS bacteria were localized freely in the cytoplasm or a few were in phagosomes without an intact limiting membrane (Fig. 1a). By contrast, >99 % of the
iglC bacteria were localized in phagosomes with intact membranes (Fig. 1b). When the
iglC strain was complemented with the iglC gene, the majority (60 %) of the bacteria were found in the cytoplasm (Fig. 1c).
|
Effect of IFN-
treatment on the intracellular localization of F. tularensis
In view of the bactericidal effect resulting from IFN-
activation of the PECs, we asked whether this treatment influenced the intracellular localization of bacteria. As expected, >99 % of the bacteria of the
iglC strain were found in phagosomes with intact membranes (not shown). In contrast, the majority of F. tularensis LVS bacteria were still found in the peripheral parts of the cytoplasm and a mean of one to two bacteria per section was observed. Some bacteria were present in vacuoles that were only partially surrounded by the limiting membrane (14 %) and most were free in the cytoplasm (66 %). However, the number of bacteria that were clearly seen within phagosomes with intact membranes (Fig. 2) was higher in treated cells than in cells without IFN-
treatment, 20 versus 3 % (P < 0.0001). Most of the intracellular F. tularensis LVS and
iglC bacteria exhibited an intact morphology (Figs 1 and 2).
|
Analysis of the lipid composition of F. tularensis LVS and the
iglC strain
It has been observed in previous studies that F. tularensis LVS-infected cells contain intra- and extra-phagosomal vesicles, presumably derived from surface-localized material released by the bacterium (Anthony et al., 1991; Golovliov et al., 2003a). We now asked whether there were changes in the composition of the
iglC mutant that could explain its lack of phagosomal escape. To this end, we investigated the total lipid composition of the two strains. The total lipid composition of F. tularensis LVS was similar to that reported previously (Anderson & Bhatti, 1986) and no significant differences were found between the two strains (data not shown). Thus there appear to be no changes in the lipid composition of the
iglC strain that could explain its lack of escape from the phagosome.
| DISCUSSION |
|---|
|
|
|---|
iglC. The analysis of total fatty acids, however, indicated no differences between the two strains. A comparative analysis in the subspecies F. novicida revealed no changes in the protein pattern of a
iglC strain besides the lack of the 23 kDa protein (Lauriano et al., 2004). Thus the findings do not give any clues that explain the function of IglC but exclude changes in total lipid composition or regulatory effects of IglC that affect the expression of other bacterial proteins. When we analysed the properties of the complemented
iglC strain, the number of bacteria free in the cytoplasm was lower than in the case of F. tularensis LVS (60 vs 97 %). This shows that the complementation, which is dependent on expression of IglC from a plasmid containing the GroEL promoter of F. tularensis, does not fully restore the wild-type phenotype. Presumably this is due to a lack of up-regulation of the plasmid expression during the intracellular phase. Nevertheless, there was a highly significant difference between bacteria of the
iglC strain and of the complemented strain in their ability to escape from the phagosome (< 1 vs 60 %, respectively).
The crucial role of IFN-
for the control and eradication of tularaemia resembles that of many other intracellular infections (Shtrichman & Samuel, 2001). The specific effects of IFN-
for activation of the cidal macrophages have been very thoroughly studied for experimental listeriosis (Prada- Delgado et al., 2001). L. monocytogenes is retained within the vacuole after IFN-
treatment by a mechanism dependent on both reactive oxygen and nitrogen intermediates (Myers et al., 2003). A key action has been attributed to Rab5a, which causes remodelling of the phagosomal environment, affects the GTPase Rac2 and subsequently increases the NADPH oxidase activity (Prada-Delgado et al., 2001). Although we also observed an increase in the number of F. tularensis in the phagosome of IFN-
-activated cells, the majority of bacteria still escaped. This finding appears paradoxical in view of the control and eradication that is afforded by the IFN-
treatment and is in contrast to the findings on L. monocytogenes. Normally, it is assumed that the escape of an intracellular organism into the cytoplasm will shield it from bactericidal mechanisms (Goebel & Kuhn, 2000). However, in view of the results, we propose that the majority of the F. tularensis bacteria that escape are incapable of intracellular multiplication. It is possible that the effects of reactive nitrogen and oxidative intermediates and other effectors active in a phagolysosome of IFN-
-activated cells will be sufficient for inducing irreversible damage during the intra-phagosomal phase that prevents subsequent bacterial multiplication but not the mechanisms required for the escape. Even though they gain access to the cytoplasm, they may be metabolically defective and eventually succumb as demonstrated by the significant decrease of bacterial numbers within 18 h. Still, the escape from the phagosome appears to be critical for avoiding rapid effects of the IFN-
activation as evidenced by the significant killing of the mutant within 5 h.
The intracellular fate of
iglC was distinct from the parent strain, F. tularensis LVS. Whereas the latter is attenuated in mice when injected via the intradermal route, it is highly virulent by other routes and also capable of rapid multiplication in mouse and human monocytic cells (Golovliov et al., 2003a). In contrast, we found that the iglC mutant bacteria were incapable of multiplying intracellularly, and in IFN-
-treated cells, almost all
iglC bacteria were killed within 18 h. We believe that one important explanation for the impaired ability of
iglC to multiply intracellularly is its inability to escape from the phagosome. However, we cannot conclude that this is the only explanation for the control and killing since we have demonstrated that
iglC, in contrast to F. tularensis LVS, lacks the ability to inhibit TLR-mediated activation of intracellular pathways and secretion of tumour necrosis factor alpha (Telepnev et al., 2003). Thus it is possible that
iglC lacks several traits of F. tularensis LVS that are important for intracellular survival and multiplication. The exact role of IglC is still elusive and understanding this function will be an important first step in understanding the intracellular survival mechanisms of F. tularensis in general.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. L. Clemens, B.-Y. Lee, and M. A. Horwitz Francisella tularensis Phagosomal Escape Does Not Require Acidification of the Phagosome Infect. Immun., May 1, 2009; 77(5): 1757 - 1773. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Schmerk, B. N. Duplantis, P. L. Howard, and F. E. Nano A Francisella novicida pdpA mutant exhibits limited intracellular replication and remains associated with the lysosomal marker LAMP-1 Microbiology, May 1, 2009; 155(5): 1498 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Broms, M. Lavander, and A. Sjostedt A Conserved {alpha}-Helix Essential for a Type VI Secretion-Like System of Francisella tularensis J. Bacteriol., April 15, 2009; 191(8): 2431 - 2446. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Schulert, R. L. McCaffrey, B. W. Buchan, S. R. Lindemann, C. Hollenback, B. D. Jones, and L.-A. H. Allen Francisella tularensis Genes Required for Inhibition of the Neutrophil Respiratory Burst and Intramacrophage Growth Identified by Random Transposon Mutagenesis of Strain LVS Infect. Immun., April 1, 2009; 77(4): 1324 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Qin, D. W. Scott, J. A. Thompson, and B. J. Mann Identification of an Essential Francisella tularensis subsp. tularensis Virulence Factor Infect. Immun., January 1, 2009; 77(1): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chong, T. D. Wehrly, V. Nair, E. R. Fischer, J. R. Barker, K. E. Klose, and J. Celli The Early Phagosomal Stage of Francisella tularensis Determines Optimal Phagosomal Escape and Francisella Pathogenicity Island Protein Expression Infect. Immun., December 1, 2008; 76(12): 5488 - 5499. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Fuller, R. R. Craven, J. D. Hall, T. M. Kijek, S. Taft-Benz, and T. H. Kawula RipA, a Cytoplasmic Membrane Protein Conserved among Francisella Species, Is Required for Intracellular Survival Infect. Immun., November 1, 2008; 76(11): 4934 - 4943. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Richards, S. L. Michell, and P. C. F. Oyston An intracellularly inducible gene involved in virulence and polyphosphate production in Francisella J. Med. Microbiol., October 1, 2008; 57(10): 1183 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bonquist, H. Lindgren, I. Golovliov, T. Guina, and A. Sjostedt MglA and Igl Proteins Contribute to the Modulation of Francisella tularensis Live Vaccine Strain-Containing Phagosomes in Murine Macrophages Infect. Immun., August 1, 2008; 76(8): 3502 - 3510. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Mares, S. S. Ojeda, E. G. Morris, Q. Li, and J. M. Teale Initial Delay in the Immune Response to Francisella tularensis Is Followed by Hypercytokinemia Characteristic of Severe Sepsis and Correlating with Upregulation and Release of Damage-Associated Molecular Patterns Infect. Immun., July 1, 2008; 76(7): 3001 - 3010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Ludu, O. M. de Bruin, B. N. Duplantis, C. L. Schmerk, A. Y. Chou, K. L. Elkins, and F. E. Nano The Francisella Pathogenicity Island Protein PdpD Is Required for Full Virulence and Associates with Homologues of the Type VI Secretion System J. Bacteriol., July 1, 2008; 190(13): 4584 - 4595. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Cole, A. Santiago, E. Barry, T. J. Kang, K. A. Shirey, Z. J. Roberts, K. L. Elkins, A. S. Cross, and S. N. Vogel Macrophage Proinflammatory Response to Francisella tularensis Live Vaccine Strain Requires Coordination of Multiple Signaling Pathways J. Immunol., May 15, 2008; 180(10): 6885 - 6891. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Buchan, M. K. McLendon, and B. D. Jones Identification of Differentially Regulated Francisella tularensis Genes by Use of a Newly Developed Tn5-Based Transposon Delivery System Appl. Envir. Microbiol., May 1, 2008; 74(9): 2637 - 2645. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Maier, M. S. Casey, R. H. Becker, C. W. Dorsey, E. M. Glass, N. Maltsev, T. C. Zahrt, and D. W. Frank Identification of Francisella tularensis Himar1-Based Transposon Mutants Defective for Replication in Macrophages Infect. Immun., November 1, 2007; 75(11): 5376 - 5389. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Cole, K. A. Shirey, E. Barry, A. Santiago, P. Rallabhandi, K. L. Elkins, A. C. Puche, S. M. Michalek, and S. N. Vogel Toll-Like Receptor 2-Mediated Signaling Requirements for Francisella tularensis Live Vaccine Strain Infection of Murine Macrophages Infect. Immun., August 1, 2007; 75(8): 4127 - 4137. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Mohapatra, S. Soni, B. L. Bell, R. Warren, R. K. Ernst, A. Muszynski, R. W. Carlson, and J. S. Gunn Identification of an Orphan Response Regulator Required for the Virulence of Francisella spp. and Transcription of Pathogenicity Island Genes Infect. Immun., July 1, 2007; 75(7): 3305 - 3314. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Lindemann, M. K. McLendon, M. A. Apicella, and B. D. Jones An In Vitro Model System Used To Study Adherence and Invasion of Francisella tularensis Live Vaccine Strain in Nonphagocytic Cells Infect. Immun., June 1, 2007; 75(6): 3178 - 3182. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Malik, C. S. Bakshi, K. McCabe, S. V. Catlett, A. Shah, R. Singh, P. L. Jackson, A. Gaggar, D. W. Metzger, J. A. Melendez, et al. Matrix Metalloproteinase 9 Activity Enhances Host Susceptibility to Pulmonary Infection with Type A and B Strains of Francisella tularensis J. Immunol., January 15, 2007; 178(2): 1013 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Balagopal, A. S. MacFarlane, N. Mohapatra, S. Soni, J. S. Gunn, and L. S. Schlesinger Characterization of the Receptor-Ligand Pathways Important for Entry and Survival of Francisella tularensis in Human Macrophages Infect. Immun., September 1, 2006; 74(9): 5114 - 5125. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Nix, K. K. M. Cheung, D. Wang, N. Zhang, R. D. Burke, and F. E. Nano Virulence of Francisella spp. in Chicken Embryos. Infect. Immun., August 1, 2006; 74(8): 4809 - 4816. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Cole, K. L. Elkins, S. M. Michalek, N. Qureshi, L. J. Eaton, P. Rallabhandi, N. Cuesta, and S. N. Vogel Immunologic Consequences of Francisella tularensis Live Vaccine Strain Infection: Role of the Innate Immune Response in Infection and Immunity. J. Immunol., June 1, 2006; 176(11): 6888 - 6899. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Pammit, E. K. Raulie, C. M. Lauriano, K. E. Klose, and B. P. Arulanandam Intranasal Vaccination with a Defined Attenuated Francisella novicida Strain Induces Gamma Interferon-Dependent Antibody-Mediated Protection against Tularemia Infect. Immun., April 1, 2006; 74(4): 2063 - 2071. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Maier, R. Pechous, M. Casey, T. C. Zahrt, and D. W. Frank In Vivo Himar1-Based Transposon Mutagenesis of Francisella tularensis. Appl. Envir. Microbiol., March 1, 2006; 72(3): 1878 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Twine, M. Bystrom, W. Chen, M. Forsman, I. Golovliov, A. Johansson, J. Kelly, H. Lindgren, K. Svensson, C. Zingmark, et al. A Mutant of Francisella tularensis Strain SCHU S4 Lacking the Ability To Express a 58-Kilodalton Protein Is Attenuated for Virulence and Is an Effective Live Vaccine Infect. Immun., December 1, 2005; 73(12): 8345 - 8352. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mariathasan, D. S. Weiss, V. M. Dixit, and D. M. Monack Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis J. Exp. Med., October 17, 2005; 202(8): 1043 - 1049. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |